Industry Looking For More “Abbreviated” Review Times In 510(k) Program
This article was originally published in The Gray Sheet
Executive Summary
Lackluster industry participation in the abbreviated 510(k) and third-party review programs could hinder efforts to adopt provisions giving device manufacturers the option of being inspected by a third party
You may also be interested in...
510(k) Review Times, CDRH Personnel Moves Unveiled At RAPS
Improved coordination between CDRH premarket guidance and standards development will be facilitated by Office of Device Evaluation Deputy Director Phil Phillips, who is assuming a parallel role as deputy director of the Office of Science & Technology
510(k) Review Times, CDRH Personnel Moves Unveiled At RAPS
Improved coordination between CDRH premarket guidance and standards development will be facilitated by Office of Device Evaluation Deputy Director Phil Phillips, who is assuming a parallel role as deputy director of the Office of Science & Technology
CDRH’s Marlowe To Coordinate FDA Science Standards; Kessler Will Head OST
Donald Marlowe, director of the Office of Science & Technology at the device center since April 1995, stepped into the newly created position of standards administrator for FDA's Office of Science & Health Coordination Oct. 7